The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

Jim Jones, the head of the Food and Drug Administration, reportedly cited recent cuts at the US agency for his decision.

Attorney Kyle Diamantas is expected to be announced as the new deputy commissioner for human foods at the US Food and Drug ...

Several prominent government officials have decided to resign from the Trump Administration. Here's what to know.

Dr. Tom Frieden, a former CDC director under President Barack Obama and the current president and CEO of the health advocacy ...

YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic ...

A Stockton drug addict who threatened to carry out a strip search of a vulnerable pensioner before punching him to the head has been locked up.

Celebrity doctor Mehmet Oz, MD, Trump's pick to head CMS, pledged to divest millions from drug, medical, and insurance ...

This case shows an abject failure in policing,” said Stochaj. “When Officer Pritchett encounters George, either due to ...

Microba Life Sciences (ASX:MAP), which has technology for measuring the gut microbiome, has a strategic partnership deal with ...

Calley Means, who is serving as an adviser to RFK Jr., interjected as Brown asked her other guest, infectious disease ...

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.